Drut M, Zàrate JO

Language: Spanish
References: 11
Page: 246-250
PDF size: 231.99 Kb.

Text Extraction

No abstract

REFERENCES

1. Feit LR. Genetics of congenital heart disease: strategies. Adv Pediatr 1998;45:267-92.

2. Ming JE, Stiehm ER, Graham JM Jr. Syndromes associated with immunodeficiency. Adv Pediatr 1999;46:271-351.

3. Birth defect encyclopedia. Buyse ML, editor. Cambridge, MA: Blackwell Scientific publications, 1990.

4. Pediatric neoplasia. Morphology and biology. Parham DM, editor. Philadelphia: Lippincott-Raven, 1996.

5. Ladanyi M, Bridge JA. Contribution of molecular genetic data to the classification of sarcomas. Hum Pathol 2000;31:532-8.

6. Ogino S, Ro TY, Redline RW. Malignant rhabdoid tumor: a phenotype? An entity? A controversy revisited. Adv Anat Pathol 2000;7:181-90.

7. Meis JM, Enzinger FM, Martz KL, Neal JA. Malignant peripheral nerve sheath tumors (malignant schwannomas) in children. Am J Surg Pathol 1992;16:694-707.

8. Rao UN, Surti U, Hoffner L, Yaw K. Cytogenetic and histologic correlation of peripheral nerve sheath tumors of soft tissue. Cancer Genet Cytogenet 1996;88:17-25.

9. Bijlsma EK, Brouwer-Mladin R, Bosch DA, Westerveld A, Hulsebos TJ. Molecular characterization of chromosome 22 deletions in schwannomas. Genes Chromosomes Cancer 1992;5:201-5.

10. WHO classification of tumors. Pathology and genetics. Tumors of the nervous system. Kleihues P, Cavenee W, editors. Lyon: IARC Press, 2000.

11. Wang WL, Mayordomo E, Czerniak BA, Abruzzo LV, et al. Fluorescence in situ hybridization is a useful ancillary diagnostic tool for extraskeletal myxoid chondrosarcoma. Mod Pathol 2008;21:1303-10.